INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
申请人:ViiV HEATHCARE UK (NO.5) LIMITED
公开号:US20180072997A1
公开(公告)日:2018-03-15
Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. Formula I is exemplified below: